Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025)
Creative Medical Technology Holdings (CELZ) posted quarterly Gross Profit of $2006.0 for Q4 2025, up 11.44% year-over-year from $1800.0 in Q4 2024, and up 11.44% quarter-over-quarter from $1800.0 in Q1 2025.
Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Gross Profit for 9 consecutive years, with $2006.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Profit rose 11.44% year-over-year to $2006.0; the TTM figure through Mar 2026 stood at $2006.0 (down 76.12% YoY), while the FY2025 annual figure was $3806.0, down 42.33% from the prior year.
- Gross Profit rose to $2006.0 in Q4 2025 per CELZ's latest filing, from $1800.0 in the prior quarter.
- Across five years, Gross Profit topped out at $39000.0 in Q3 2022 and bottomed at $1800.0 in Q4 2023.
- Historically, Gross Profit has averaged $9643.3 across 5 years, with a median of $5150.0 in 2021.
- Annual changes were most pronounced in 2022 — Gross Profit jumped 550.0% — and 2023, when it sank 90.77%.
- Creative Medical Technology Holdings' Gross Profit stood at $28305.0 in 2021, then plunged by 54.43% to $12900.0 in 2022, then plunged by 86.05% to $1800.0 in 2023, then changed by 0.0% to $1800.0 in 2024, then rose by 11.44% to $2006.0 in 2025.
- Business Quant data shows CELZ's Gross Profit at $2006.0 in Q4 2025, $1800.0 in Q1 2025, and $1800.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,006.00 |
| Dec 31, 2025 | 2,006.00 |
| Mar 31, 2025 | 1,800.00 |
| Mar 31, 2025 | 1,800.00 |
| Dec 31, 2024 | 1,800.00 |
| Dec 31, 2024 | 1,800.00 |
| Jun 30, 2024 | 4,800.00 |
| Jun 30, 2024 | 4,800.00 |
| Dec 31, 2023 | 1,800.00 |
| Dec 31, 2023 | 1,800.00 |
| Sep 30, 2023 | 3,600.00 |
| Sep 30, 2023 | 3,600.00 |
| Dec 31, 2022 | 12,900.00 |
| Dec 31, 2022 | 12,900.00 |
| Sep 30, 2022 | 39,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 8,209.00 |
| Mar 31, 2022 | 8,209.00 |
| Dec 31, 2021 | 28,305.00 |
| Dec 31, 2021 | 28,305.00 |